Support Alert

Class 2 medicines recall: Grünenthal Ltd, Palexia 20 mg/ml Oral Solution

Grünenthal Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling batches of Palexia 20 mg/ml Oral Solution due to potential microbial contamination during routine stability testing. This recall affects all batches of oral solution in the UK market that are still within their expiry date.

Further information including the affected batch numbers, a brief description of the problem and advice for patients and healthcare professionals can be found on the MHRA website.


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.